Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 3,840.00
-30.00 (-0.78%)
At close: Jun 5, 2025, 3:30 PM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 282.19 billion as of June 16, 2025. Its market cap has increased by 11.10% in one year.
Market Cap
282.19B
Enterprise Value
362.96B
Revenue
6.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,840.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 282.19B, a decrease of -53.99%. That is a compound annual growth rate of -16.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 282.19B | -28.39% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 381.06T |
| SK hynix | 162.58T |
| Samsung Biologics | 72.53T |
| LG Energy Solution | 69.26T |
| Hanwha Aerospace | 44.59T |
| Hyundai Motor Company | 43.49T |
| HD Hyundai Heavy Industries | 37.95T |
| Kia Corporation | 37.89T |